Sana Biotechnology, Inc. (SANA) Misses Q1 EPS by 19c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q1 EPS of ($0.49), $0.19 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• Alcoa closes $2.6B debt offering to fund South32 asset acquisition
• AutoZone (AZO) PT Lowered to $4,230 at UBS Following 'Underwhelming' Q4 Print